Events
![Road to Biologic IND Event Poster](https://labcentral-site.transforms.svdcdn.com/production/labcentralorg/images/events/Road_to_Biologic_IND-EventPoster.jpg?w=1120&h=300&fm=webp&auto=compress&fit=crop&crop=top&dm=1693574677&s=12eafeab40a54ffc4c8b57cf05cc13c1)
The Road to the Biologic IND
September 11, 2014
Janssen Labs
Time: 8:00AM – 11:00AM
Location: LabCentral Lobby
RSVP after requesting the LabCentral code for free entry from Krista
Janssen Labs, the Johnson & Johnson Innovation Center in Boston and the Janssen Biotechnology Center of Excellence invite you to an in-depth look into the process of filing a biologic Investigational New Drug (IND) application and the procedures necessary for advancing your company's early-stage drug development program. Whether your goal is to develop a pipeline through commercial launch, or partner as early as possible, submitting an IND is a critical early milestone for every biotech company. With big Pharma and VC firms competing for the most promising compounds, startups are expected to demonstrate a solid plan for achieving IND acceptance. Join us for a series of short presentations exploring the basic requirements and considerations necessary to achieve a successful biologic IND submission. Please see RSVP for more details.